Rigel Pharmaceuticals
RIGL
RIGL
136 hedge funds and large institutions have $316M invested in Rigel Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 8.8% → 8.83% (+0.03%)
82% less call options, than puts
Call options by funds: $16K | Put options by funds: $89K
Holders
136
Holding in Top 10
–
Calls
$16K
Puts
$89K
Top Buyers
| 1 | +$2.78M | |
| 2 | +$2.32M | |
| 3 | +$2.19M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.97M |
| 5 |
Millennium Management
New York
|
+$1.88M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$1.35M | |
| 3 | -$1.33M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.05M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.05M |